Literature DB >> 18041513

Dental management of a talon cusp on a primary incisor.

Richard K Yoon1, Steven Chussid.   

Abstract

There are many treatment options for the pediatric patient with a talon cusp (TC). The purpose of this paper was to report the case of a TC involving a primary maxillary right central incisor in a 14-month-old male causing displacement of the affected tooth. The etiology of a TC is thought to be a disturbance during the morphodifferentiation stage of tooth development. Clinical problems include: (1) occlusal interferences; (2) esthetic disturbances; (3) accidental cusp fracture; (4) tongue irritation; (5) nursing difficulty; (6) caries; and (7) displacement of the affected tooth. The TC affecting the central incisor was reduced over a period of 4 visits, followed by immediate placement of a 5% sodium fluoride varnish at the conclusion of each reduction visit. Restoration of esthetics and function was evident within 1 month following complete cusp reduction. There were no clinical signs of any problems related to the reduction, and the prognosis was considered to be guarded. The pediatric patient was placed on a 6-month oral hygiene maintenance follow-up.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18041513

Source DB:  PubMed          Journal:  Pediatr Dent        ISSN: 0164-1263            Impact factor:   1.874


  3 in total

1.  Variants of Talon Cusp (Dens Evaginatus).

Authors:  Mythri Sarpangala; Ashwin Devasya
Journal:  J Clin Diagn Res       Date:  2017-01-01

2.  Prevalence and characteristics of talon cusps in Turkish population.

Authors:  Yeliz Guven; Yelda Kasimoglu; Elif Bahar Tuna; Koray Gencay; Oya Aktoren
Journal:  Dent Res J (Isfahan)       Date:  2016 Mar-Apr

3.  Clinical Orodental Anomalies in Taiwanese Children under Age Six: a Study Based on the 1995-1997 National Dental Survey.

Authors:  Po-Sen Chang; Tzung-Hai Yen; Chun-Jui Huang; Amy Ming-Fang Yen; Sam Li-Sheng Chen; Aileen I Tsai
Journal:  Biomed Res Int       Date:  2020-07-19       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.